COVID-19's Pathways to Human Central Nervous System and Relevant Drug Treatment

0Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

COVID-19, also known as Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2), is a severe disease. It can cause different types of symptoms including shortness of breath, fever, cough, fatigue and sore throat. Older adults and people who have severe underlying medical conditions like aart or lung disease or diabetes seem to be at hig ar risk to develop more complex complications due to the infection. Until August 6th, 2020, COVID-19 has caused 700, 000 deaths across the Earth; however, the actual death number could be hig ar than 700,000. COVID-19's origin is still remained unknown, but the speculation is targeted to bats or pangolins. Although COVID-19 is a disease target human's respiratory system, based on the research and clinical cases of COVID-19, evidence shows that COVID-19 can also invade human's central nervous system (CNS).

Cite

CITATION STYLE

APA

Liang, Z. (2020). COVID-19’s Pathways to Human Central Nervous System and Relevant Drug Treatment. In E3S Web of Conferences (Vol. 218). EDP Sciences. https://doi.org/10.1051/e3sconf/202021803009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free